Do analysts rate RXST or POCI?

RxSight currently has a consensus price target of $9.44, suggesting a potential upside of 82.68%. Given RxSight's stronger consensus rating and higher possible upside, equities research analysts plainly believe RxSight is more favorable than Precision Optics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RxSight 3 Sell rating(s) 10 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.93 Precision Optics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is RXST or POCI more profitable?

Precision Optics has a net margin of -17.03% compared to RxSight's net margin of -36.58%. RxSight's return on equity of -17.01% beat Precision Optics' return on equity. Company Net Margins Return on Equity Return on Assets RxSight -36.58% -17.01% -15.12% Precision Optics -17.03% -37.47% -19.96%

Does the media refer more to RXST or POCI?

In the previous week, Precision Optics had 1 more articles in the media than RxSight. MarketBeat recorded 4 mentions for Precision Optics and 3 mentions for RxSight. Precision Optics' average media sentiment score of 0.72 beat RxSight's score of 0.62 indicating that Precision Optics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RxSight 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Precision Optics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer POCI or SMTI?

Sanara MedTech has a consensus price target of $34.00, suggesting a potential upside of 40.09%. Given Sanara MedTech's stronger consensus rating and higher possible upside, analysts plainly believe Sanara MedTech is more favorable than Precision Optics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Precision Optics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Sanara MedTech 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.60

Do analysts recommend LUCD or POCI?

Lucid Diagnostics currently has a consensus price target of $4.19, indicating a potential upside of 298.81%. Given Lucid Diagnostics' stronger consensus rating and higher possible upside, research analysts clearly believe Lucid Diagnostics is more favorable than Precision Optics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lucid Diagnostics 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60 Precision Optics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate POCI or PDEX?

Pro-Dex has a consensus target price of $70.00, indicating a potential upside of 11.57%. Given Pro-Dex's stronger consensus rating and higher possible upside, analysts clearly believe Pro-Dex is more favorable than Precision Optics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Precision Optics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Pro-Dex 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33

Which has preferable earnings & valuation, POCI or PDEX?

Pro-Dex has higher revenue and earnings than Precision Optics. Precision Optics is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Precision Optics $19.09M 2.95 -$5.78M -$0.63 N/A Pro-Dex $66.59M 3.01 $8.98M $3.62 17.33

Is POCI or PDEX more profitable?

Pro-Dex has a net margin of 16.08% compared to Precision Optics' net margin of -17.03%. Pro-Dex's return on equity of 22.78% beat Precision Optics' return on equity. Company Net Margins Return on Equity Return on Assets Precision Optics -17.03% -37.47% -19.96% Pro-Dex 16.08% 22.78% 14.30%

Does the media prefer POCI or PDEX?

In the previous week, Precision Optics had 2 more articles in the media than Pro-Dex. MarketBeat recorded 4 mentions for Precision Optics and 2 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 0.94 beat Precision Optics' score of 0.72 indicating that Pro-Dex is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Precision Optics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Pro-Dex 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate KRMD or POCI?

KORU Medical Systems currently has a consensus target price of $7.25, indicating a potential upside of 64.77%. Given KORU Medical Systems' stronger consensus rating and higher probable upside, equities analysts clearly believe KORU Medical Systems is more favorable than Precision Optics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score KORU Medical Systems 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60 Precision Optics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor KRMD or POCI?

In the previous week, Precision Optics had 2 more articles in the media than KORU Medical Systems. MarketBeat recorded 4 mentions for Precision Optics and 2 mentions for KORU Medical Systems. Precision Optics' average media sentiment score of 0.72 beat KORU Medical Systems' score of 0.62 indicating that Precision Optics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment KORU Medical Systems 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Precision Optics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Precision Optics (POCI) Competitors

$5.14 +0.04 (+0.78%)

Closing price 07/1/2026 04:00 PM Eastern

Extended Trading

$5.07 -0.07 (-1.36%)

As of 07/1/2026 04:10 PM Eastern

Compare

POCI vs. RXST, SMTI, LUCD, PDEX, and KRMD

Should you buy Precision Optics stock or one of its competitors? MarketBeat compares Precision Optics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Precision Optics include RxSight (RXST), Sanara MedTech (SMTI), Lucid Diagnostics (LUCD), Pro-Dex (PDEX), and KORU Medical Systems (KRMD). These companies are all part of the "medical equipment" industry.

How does Precision Optics compare to RxSight?

RxSight (NASDAQ:RXST) and Precision Optics (NASDAQ:POCI) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, media sentiment, earnings, institutional ownership, valuation, dividends and profitability.

RxSight currently has a consensus price target of $9.44, suggesting a potential upside of 82.68%. Given RxSight's stronger consensus rating and higher possible upside, equities research analysts plainly believe RxSight is more favorable than Precision Optics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RxSight	3 Sell rating(s)	10 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.93
Precision Optics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

RxSight has a beta of 1.15, suggesting that its stock price is 15% more volatile than the broader market. Comparatively, Precision Optics has a beta of 0.32, suggesting that its stock price is 68% less volatile than the broader market.

Precision Optics has a net margin of -17.03% compared to RxSight's net margin of -36.58%. RxSight's return on equity of -17.01% beat Precision Optics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RxSight	-36.58%	-17.01%	-15.12%
Precision Optics	-17.03%	-37.47%	-19.96%

Precision Optics has lower revenue, but higher earnings than RxSight. Precision Optics is trading at a lower price-to-earnings ratio than RxSight, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RxSight	$134.48M	1.59	-$38.94M	-$1.13	N/A
Precision Optics	$19.09M	2.95	-$5.78M	-$0.63	N/A

78.8% of RxSight shares are held by institutional investors. Comparatively, 13.7% of Precision Optics shares are held by institutional investors. 10.1% of RxSight shares are held by company insiders. Comparatively, 14.4% of Precision Optics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Precision Optics had 1 more articles in the media than RxSight. MarketBeat recorded 4 mentions for Precision Optics and 3 mentions for RxSight. Precision Optics' average media sentiment score of 0.72 beat RxSight's score of 0.62 indicating that Precision Optics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RxSight	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Precision Optics	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

RxSight beats Precision Optics on 9 of the 16 factors compared between the two stocks.

How does Precision Optics compare to Sanara MedTech?

Precision Optics (NASDAQ:POCI) and Sanara MedTech (NASDAQ:SMTI) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability.

13.7% of Precision Optics shares are held by institutional investors. Comparatively, 8.1% of Sanara MedTech shares are held by institutional investors. 14.4% of Precision Optics shares are held by insiders. Comparatively, 42.0% of Sanara MedTech shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Precision Optics has higher earnings, but lower revenue than Sanara MedTech. Precision Optics is trading at a lower price-to-earnings ratio than Sanara MedTech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Precision Optics	$19.09M	2.95	-$5.78M	-$0.63	N/A
Sanara MedTech	$103.12M	2.16	-$37.56M	-$3.77	N/A

Sanara MedTech has a consensus price target of $34.00, suggesting a potential upside of 40.09%. Given Sanara MedTech's stronger consensus rating and higher possible upside, analysts plainly believe Sanara MedTech is more favorable than Precision Optics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Precision Optics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Sanara MedTech	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60

Precision Optics has a net margin of -17.03% compared to Sanara MedTech's net margin of -31.23%. Sanara MedTech's return on equity of -3.19% beat Precision Optics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Precision Optics	-17.03%	-37.47%	-19.96%
Sanara MedTech	-31.23%	-3.19%	-0.56%

Precision Optics has a beta of 0.32, meaning that its stock price is 68% less volatile than the broader market. Comparatively, Sanara MedTech has a beta of 1.18, meaning that its stock price is 18% more volatile than the broader market.

In the previous week, Precision Optics had 3 more articles in the media than Sanara MedTech. MarketBeat recorded 4 mentions for Precision Optics and 1 mentions for Sanara MedTech. Sanara MedTech's average media sentiment score of 1.89 beat Precision Optics' score of 0.72 indicating that Sanara MedTech is being referred to more favorably in the news media.

Company	Overall Sentiment
Precision Optics	Positive
Sanara MedTech	Very Positive

Summary

Sanara MedTech beats Precision Optics on 11 of the 17 factors compared between the two stocks.

How does Precision Optics compare to Lucid Diagnostics?

Lucid Diagnostics (NASDAQ:LUCD) and Precision Optics (NASDAQ:POCI) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, media sentiment, profitability and institutional ownership.

74.0% of Lucid Diagnostics shares are held by institutional investors. Comparatively, 13.7% of Precision Optics shares are held by institutional investors. 6.9% of Lucid Diagnostics shares are held by company insiders. Comparatively, 14.4% of Precision Optics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Lucid Diagnostics currently has a consensus price target of $4.19, indicating a potential upside of 298.81%. Given Lucid Diagnostics' stronger consensus rating and higher possible upside, research analysts clearly believe Lucid Diagnostics is more favorable than Precision Optics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lucid Diagnostics	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Precision Optics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Precision Optics has higher revenue and earnings than Lucid Diagnostics. Precision Optics is trading at a lower price-to-earnings ratio than Lucid Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lucid Diagnostics	$4.71M	45.27	-$58.01M	-$0.47	N/A
Precision Optics	$19.09M	2.95	-$5.78M	-$0.63	N/A

In the previous week, Precision Optics had 3 more articles in the media than Lucid Diagnostics. MarketBeat recorded 4 mentions for Precision Optics and 1 mentions for Lucid Diagnostics. Lucid Diagnostics' average media sentiment score of 0.90 beat Precision Optics' score of 0.72 indicating that Lucid Diagnostics is being referred to more favorably in the media.

Company	Overall Sentiment
Lucid Diagnostics	Positive
Precision Optics	Positive

Precision Optics has a net margin of -17.03% compared to Lucid Diagnostics' net margin of -876.72%. Lucid Diagnostics' return on equity of 0.00% beat Precision Optics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lucid Diagnostics	-876.72%	N/A	-116.26%
Precision Optics	-17.03%	-37.47%	-19.96%

Lucid Diagnostics has a beta of 1.07, meaning that its stock price is 7% more volatile than the broader market. Comparatively, Precision Optics has a beta of 0.32, meaning that its stock price is 68% less volatile than the broader market.

Summary

Lucid Diagnostics beats Precision Optics on 10 of the 16 factors compared between the two stocks.

How does Precision Optics compare to Pro-Dex?

Precision Optics (NASDAQ:POCI) and Pro-Dex (NASDAQ:PDEX) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation, dividends and media sentiment.

Pro-Dex has a consensus target price of $70.00, indicating a potential upside of 11.57%. Given Pro-Dex's stronger consensus rating and higher possible upside, analysts clearly believe Pro-Dex is more favorable than Precision Optics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Precision Optics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Pro-Dex	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

Precision Optics has a beta of 0.32, indicating that its share price is 68% less volatile than the broader market. Comparatively, Pro-Dex has a beta of 0.02, indicating that its share price is 98% less volatile than the broader market.

In the previous week, Precision Optics had 2 more articles in the media than Pro-Dex. MarketBeat recorded 4 mentions for Precision Optics and 2 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 0.94 beat Precision Optics' score of 0.72 indicating that Pro-Dex is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Precision Optics	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Pro-Dex	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

13.7% of Precision Optics shares are owned by institutional investors. Comparatively, 15.3% of Pro-Dex shares are owned by institutional investors. 14.4% of Precision Optics shares are owned by company insiders. Comparatively, 45.9% of Pro-Dex shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Pro-Dex has a net margin of 16.08% compared to Precision Optics' net margin of -17.03%. Pro-Dex's return on equity of 22.78% beat Precision Optics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Precision Optics	-17.03%	-37.47%	-19.96%
Pro-Dex	16.08%	22.78%	14.30%

Pro-Dex has higher revenue and earnings than Precision Optics. Precision Optics is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Precision Optics	$19.09M	2.95	-$5.78M	-$0.63	N/A
Pro-Dex	$66.59M	3.01	$8.98M	$3.62	17.33

Summary

Pro-Dex beats Precision Optics on 14 of the 16 factors compared between the two stocks.

How does Precision Optics compare to KORU Medical Systems?

KORU Medical Systems (NASDAQ:KRMD) and Precision Optics (NASDAQ:POCI) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation and institutional ownership.

KORU Medical Systems has higher revenue and earnings than Precision Optics. KORU Medical Systems is trading at a lower price-to-earnings ratio than Precision Optics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$41.13M	4.91	-$2.64M	-$0.05	N/A
Precision Optics	$19.09M	2.95	-$5.78M	-$0.63	N/A

In the previous week, Precision Optics had 2 more articles in the media than KORU Medical Systems. MarketBeat recorded 4 mentions for Precision Optics and 2 mentions for KORU Medical Systems. Precision Optics' average media sentiment score of 0.72 beat KORU Medical Systems' score of 0.62 indicating that Precision Optics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
KORU Medical Systems	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Precision Optics	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 13.7% of Precision Optics shares are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by insiders. Comparatively, 14.4% of Precision Optics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

KORU Medical Systems has a net margin of -5.27% compared to Precision Optics' net margin of -17.03%. KORU Medical Systems' return on equity of -13.61% beat Precision Optics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-5.27%	-13.61%	-8.33%
Precision Optics	-17.03%	-37.47%	-19.96%

KORU Medical Systems currently has a consensus target price of $7.25, indicating a potential upside of 64.77%. Given KORU Medical Systems' stronger consensus rating and higher probable upside, equities analysts clearly believe KORU Medical Systems is more favorable than Precision Optics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Precision Optics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

KORU Medical Systems has a beta of 0.41, indicating that its stock price is 59% less volatile than the broader market. Comparatively, Precision Optics has a beta of 0.32, indicating that its stock price is 68% less volatile than the broader market.

Summary

KORU Medical Systems beats Precision Optics on 13 of the 16 factors compared between the two stocks.

Get Precision Optics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding POCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

POCI vs. The Competition

Export

Metric	Precision Optics	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$55.82M	$7.23B	$6.79B	$12.59B
Dividend Yield	N/A	1.31%	2.66%	6.15%
P/E Ratio	-8.16	50.10	27.67	25.27
Price / Sales	2.95	81.52	533.25	101.18
Price / Cash	N/A	25.79	47.99	59.26
Price / Book	3.21	7.41	10.96	6.62
Net Income	-$5.78M	$159.19M	$3.57B	$336.83M
7 Day Performance	0.98%	0.06%	2.88%	3.19%
1 Month Performance	-10.14%	-2.81%	3.69%	0.86%
1 Year Performance	3.84%	2.41%	34.39%	27.51%

Precision Optics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
POCI Precision Optics	0.7435 of 5 stars	$5.14 +0.8%	N/A	+4.5%	$55.82M	$19.09M	N/A	80	News Coverage Short Interest Decrease Gap Up
RXST RxSight	2.6659 of 5 stars	$5.13 -3.4%	$9.44 +84.1%	-60.6%	$212.38M	$134.48M	N/A	220
SMTI Sanara MedTech	2.6311 of 5 stars	$23.12 +1.0%	$34.00 +47.1%	-15.8%	$211.78M	$103.12M	N/A	60	Positive News
LUCD Lucid Diagnostics	3.8887 of 5 stars	$1.04 +2.0%	$4.19 +302.6%	-4.5%	$211.19M	$4.71M	N/A	70
PDEX Pro-Dex	2.449 of 5 stars	$65.31 +0.9%	$70.00 +7.2%	+43.9%	$208.54M	$74.64M	18.04	140	Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:POCI) was last updated on 7/2/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Precision Optics (POCI) Competitors

POCI vs. RXST, SMTI, LUCD, PDEX, and KRMD

How does Precision Optics compare to RxSight?

Summary

How does Precision Optics compare to Sanara MedTech?

Summary

How does Precision Optics compare to Lucid Diagnostics?

Summary

How does Precision Optics compare to Pro-Dex?

Summary

How does Precision Optics compare to KORU Medical Systems?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

POCI vs. The Competition

Precision Optics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Precision Optics (POCI) Competitors

POCI vs. RXST, SMTI, LUCD, PDEX, and KRMD

How does Precision Optics compare to RxSight?

Do analysts rate RXST or POCI?

Which has more volatility and risk, RXST or POCI?

Is RXST or POCI more profitable?

Which has higher valuation and earnings, RXST or POCI?

Do insiders & institutionals hold more shares of RXST or POCI?

Does the media refer more to RXST or POCI?

Summary

How does Precision Optics compare to Sanara MedTech?

Do institutionals & insiders hold more shares of POCI or SMTI?

Which has higher valuation & earnings, POCI or SMTI?

Do analysts prefer POCI or SMTI?

Is POCI or SMTI more profitable?

Which has more risk and volatility, POCI or SMTI?

Does the media refer more to POCI or SMTI?

Summary

How does Precision Optics compare to Lucid Diagnostics?

Do insiders & institutionals have more ownership in LUCD or POCI?

Do analysts recommend LUCD or POCI?

Which has preferable valuation & earnings, LUCD or POCI?

Does the media favor LUCD or POCI?

Is LUCD or POCI more profitable?

Which has more volatility & risk, LUCD or POCI?

Summary

How does Precision Optics compare to Pro-Dex?

Do analysts rate POCI or PDEX?

Which has more risk & volatility, POCI or PDEX?

Does the media prefer POCI or PDEX?

Do insiders and institutionals believe in POCI or PDEX?

Is POCI or PDEX more profitable?

Which has preferable earnings & valuation, POCI or PDEX?

Summary

How does Precision Optics compare to KORU Medical Systems?

Which has better earnings and valuation, KRMD or POCI?

Does the media favor KRMD or POCI?

Do institutionals and insiders believe in KRMD or POCI?

Is KRMD or POCI more profitable?

Do analysts rate KRMD or POCI?

Which has more volatility and risk, KRMD or POCI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

POCI vs. The Competition

Precision Optics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools